SKF-96365
SIGMA/S7809 - ≥98% (HPLC), solid
Synonym: 1-[β-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenethyl]-1H-imidazole hydrochloride; 1-
CAS Number: 130495-35-1
Empirical Formula (Hill Notation): C22H26N2O3 · HCl
Molecular Weight: 402.91
MDL Number: MFCD00236407
Linear Formula: C22H26N2O3 · HCl
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white |
| form | solid |
| InChI | 1S/C22H26N2O3.ClH/c1-25-2 |
| InChI key | FWLPKVQUECFKSW-UHFFFAOYSA |
| Quality Level | 100 ![]() |
| SMILES string | Cl.COc1ccc(CCCOC(Cn2ccnc2 |
| solubility | DMSO: >20 mg/mL |
| H2O: >20 mg/mL |
| Application: | SKF-96365 has been used as : • a nonselective transient receptor potential 6 (TRPC6) blocker in human podocytes • an antagonist of store-operated Ca2+ influx in neurons • an inhibitor for transient receptor potential 3 (TRPC3) in mice |
| Biochem/physiol Actions: | SKF-96365 with an alkylated imidazole ring is a selective inhibitor of receptor-mediated Ca2+ entry and voltage-gated Ca2+ entry . SKF-96365 mediated depolarization of smooth cardiac muscle membrane and had no impact on the acetylcholine (ACh)-induced depolarization. It is an inhibitor for SOCE (store-operated calcium entry). It also inhibits Homer1 protein expression. SKF-96365 elicits protective functionality in 1-methyl-4-phenylpyridini |
| Packaging: | 5 mg in glass bottle |
| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| UNSPSC | 12352200 |

